Jane Street Group, LLC Igm Biosciences, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$27.59 - $66.39 $140,709 - $338,589
-5,100 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$65.76 - $90.65 $92,064 - $126,910
1,400 Added 37.84%
5,100 $335,000
Q1 2021

May 18, 2021
BUY
$71.56 - $121.23 $7,156 - $12,123
100 Added 2.78%
3,700 $284,000
Q4 2020

Feb 17, 2021
BUY
$47.41 - $115.03 $170,676 - $414,108
3,600 New
3,600 $318,000

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email